HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 564 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,886 | +9.5% | 24,946 | -2.6% | 0.01% | +20.0% |
| Q2 2023 | $2,635 | -19.8% | 25,621 | -14.9% | 0.01% | -28.6% |
| Q1 2023 | $3,286 | -8.8% | 30,109 | -4.9% | 0.01% | -22.2% |
| Q4 2022 | $3,602 | -99.8% | 31,653 | -0.1% | 0.01% | +80.0% |
| Q3 2022 | $1,961,000 | -32.1% | 31,692 | -12.5% | 0.01% | -37.5% |
| Q2 2022 | $2,889,000 | -22.7% | 36,228 | +2.0% | 0.01% | -11.1% |
| Q1 2022 | $3,736,000 | -4.1% | 35,513 | -1.8% | 0.01% | 0.0% |
| Q4 2021 | $3,896,000 | +20.1% | 36,162 | +22.1% | 0.01% | +12.5% |
| Q3 2021 | $3,243,000 | +34.6% | 29,613 | +15.1% | 0.01% | +33.3% |
| Q2 2021 | $2,409,000 | +18.6% | 25,729 | +16.5% | 0.01% | 0.0% |
| Q1 2021 | $2,032,000 | +116.4% | 22,088 | +71.9% | 0.01% | +100.0% |
| Q4 2020 | $939,000 | +44.0% | 12,847 | +53.0% | 0.00% | +50.0% |
| Q3 2020 | $652,000 | +42.0% | 8,398 | +1.7% | 0.00% | 0.0% |
| Q2 2020 | $459,000 | +83.6% | 8,261 | -2.2% | 0.00% | +100.0% |
| Q1 2020 | $250,000 | – | 8,447 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |